Designer Immune Cells Made From Patients’ Own Blood Kill Cancer

Two leukemia patients were cancer- free in three weeks after being treated with genetically engineered versions of their own immune cells, an early finding that could lead to a new approach for treating the blood cancer.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.